Search Prime Grants

HT94252310250

Project Grant

Overview

Grant Description
Understanding and overcoming treatment resistance in MDM2-amplified esophageal cancers.
Awardee
Sloan-Kettering Institute For Cancer Research
Funding Goals
AWARD MECHANISM: CAREER DEVELOPMENT AWARD - FELLOW OPTION PROGRAM: PEER REVIEWED CANCER RESEARCH PROGRAM
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
New York, New York 100656007 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH22PRCRPCDA
Analysis Notes
Amendment Since initial award the End Date has been extended from 03/31/26 to 03/31/27.
Sloan-Kettering Institute For Cancer Research was awarded Project Grant HT94252310250 worth $707,999 from Defense Health Agency in April 2023 with work to be completed primarily in New York New York United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 3/13/26

Period of Performance
4/1/23
Start Date
3/31/27
End Date
80.0% Complete

Funding Split
$708.0K
Federal Obligation
$0.0
Non-Federal Obligation
$708.0K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HT94252310250

Transaction History

Modifications to HT94252310250

Additional Detail

Award ID FAIN
HT94252310250
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
KUKXRCZ6NZC2
Awardee CAGE
6X133
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Modified: 3/13/26